These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22067671)

  • 1. Statistical learning methods as a preprocessing step for survival analysis: evaluation of concept using lung cancer data.
    Behera M; Fowler EE; Owonikoko TK; Land WH; Mayfield W; Chen Z; Khuri FR; Ramalingam SS; Heine JJ
    Biomed Eng Online; 2011 Nov; 10():97. PubMed ID: 22067671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis of patients with stage I non-small-cell lung cancer using clinical and DNA repair pathway expression variables.
    Behera M; Heine JJ; Sica GL; Fowler EE; Tran H; Fu RW; Gal AA; Hermann R; Mayfield W; Khuri FR; Owonikoko TK; Ramalingam SS
    Clin Lung Cancer; 2013 Mar; 14(2):128-38. PubMed ID: 22921042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival.
    She Y; Jin Z; Wu J; Deng J; Zhang L; Su H; Jiang G; Liu H; Xie D; Cao N; Ren Y; Chen C
    JAMA Netw Open; 2020 Jun; 3(6):e205842. PubMed ID: 32492161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new PET/CT volumetric prognostic index for non-small cell lung cancer.
    Zhang H; Wroblewski K; Jiang Y; Penney BC; Appelbaum D; Simon CA; Salgia R; Pu Y
    Lung Cancer; 2015 Jul; 89(1):43-9. PubMed ID: 25936471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
    Marchevsky AM; Patel S; Wiley KJ; Stephenson MA; Gondo M; Brown RW; Yi ES; Benedict WF; Anton RC; Cagle PT
    Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after community diagnosis of early-stage non-small cell lung cancer.
    Kanarek NF; Hooker CM; Mathieu L; Tsai HL; Rudin CM; Herman JG; Brock MV
    Am J Med; 2014 May; 127(5):443-9. PubMed ID: 24486286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network.
    Jiang N; Xu X
    Medicine (Baltimore); 2019 May; 98(20):e15642. PubMed ID: 31096483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial neural network model of survival in patients treated with irradiation with and without concurrent chemotherapy for advanced carcinoma of the head and neck.
    Bryce TJ; Dewhirst MW; Floyd CE; Hars V; Brizel DM
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):339-45. PubMed ID: 9607349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine-Learning and Stochastic Tumor Growth Models for Predicting Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer.
    Siah KW; Khozin S; Wong CH; Lo AW
    JCO Clin Cancer Inform; 2019 Sep; 3():1-11. PubMed ID: 31539267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between deficits in overall quality of life and non-small-cell lung cancer survival.
    Sloan JA; Zhao X; Novotny PJ; Wampfler J; Garces Y; Clark MM; Yang P
    J Clin Oncol; 2012 May; 30(13):1498-504. PubMed ID: 22454418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients.
    David EA; Andersen SW; Beckett LA; Melnikow J; Kelly K; Cooke DT; Brown LM; Canter RJ
    Ann Thorac Surg; 2017 Nov; 104(5):1665-1672. PubMed ID: 28964421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
    Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
    BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.
    Hosny A; Parmar C; Coroller TP; Grossmann P; Zeleznik R; Kumar A; Bussink J; Gillies RJ; Mak RH; Aerts HJWL
    PLoS Med; 2018 Nov; 15(11):e1002711. PubMed ID: 30500819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer.
    Zhao Q; Li B; Xu Y; Wang S; Zou B; Yu J; Wang L
    Cancer Med; 2021 Sep; 10(18):6291-6303. PubMed ID: 34390218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
    Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.